Ascorbic Acid Episode IV: The Rise and Fall of Vitamin C

<p>Mark P. Layden, PharmD, MBA (<a href='https://twitter.com/layden_Rx'>Twitter @Layden_Rx</a>) describes the pathophysiology of sepsis and role of Vitamin C in the critically ill population, identifies the proposed benefits of Vitamin C use in the critically ill patient population and discusses updated literature on the current role of Vitamin C in sepsis.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>